Published in Thorax on March 01, 1983
Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax (1986) 0.97
Refractory period following bronchoconstriction provoked by histamine in asthmatic subjects. Thorax (1989) 0.92
Effects of calcium channel blockade on histamine induced bronchoconstriction in mild asthma. Thorax (1984) 0.81
Indomethacin inhibits the increased airway responsiveness to histamine following inhalation of C5a des Arg in rabbits. Agents Actions (1986) 0.77
Bronchial hyperreactivity to histamine in aspirin sensitive asthmatics: relationship to aspirin threshold and effect of aspirin desensitisation. Thorax (1985) 0.75
A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest (1956) 14.82
Bronchial hyperreactivity. Br J Dis Chest (1975) 3.70
A new preparation of the isolated intact trachea of the guinea-pig. J Pharm Pharmacol (1970) 2.58
Antagonism of tone and prostaglandin-mediated responses in a tracheal preparation by indomethacin and SC-19220. Br J Pharmacol (1974) 2.19
The inducement of tone and its inhibition in isolated tracheal muscle. J Pharm Pharmacol (1971) 1.95
Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine. Am Rev Respir Dis (1980) 1.90
Airway response to carbachol in normal and asthmatic subjects: distinction between bronchial sensitivity and reactivity. Am Rev Respir Dis (1977) 1.81
Endogenous prostaglandins and osmotic water flow in the toad bladder. Am J Physiol (1972) 1.51
Inhibition of prostaglandin synthesis in man. Biochem Biophys Res Commun (1972) 1.43
Induction of bronchial hypersensitivity: evidence for a role for prostaglandins. Thorax (1981) 1.34
Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther (1978) 1.33
Generation of prostaglandin E-like material by the guinea-pig trachea contracted by histamine. J Pharm Pharmacol (1975) 1.27
Contractile and relaxant actions of prostaglandins on guinea-pig isolated trachea. Br J Pharmacol (1980) 1.25
Stimulation of the antigen-induced contraction of guinea-pig trachea and immunological release of histamine and SRS-A from sensitized guinea-pig lung by (2-isopropyl-3-indolyl)-3 pyridyl ketone (L8027) and indomethacin. Br J Pharmacol (1980) 1.00
Time-dependent effect of prostaglandin E2 inhalation on airway responses to bronchoconstrictor agents in normal subjects. Thorax (1982) 0.99
Indomethacin serum concentrations in man. Effects of dosage, food, and antacid. Ann Rheum Dis (1976) 0.99
Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects: evidence for altered arachidonic acid metabolism in asthma. Am Rev Respir Dis (1981) 0.97
Multiple sites of interaction between prostaglandins and non-steroidal anti-inflammatory agents. Prostaglandins (1975) 0.96
Endogenous prostaglandins and mechanical tension in canine trachealis muscle. Am J Physiol (1976) 0.96
Dual effect of prostaglandin E2 on normal airways smooth muscle in vivo. Thorax (1982) 0.90
Interactions between response to inhaled prostaglandin E2 and chronic beta-adrenergic agonist treatment. Thorax (1982) 0.81
Enhancement of antigen-induced tracheal contraction by cyclooxygenase inhibition. Adv Prostaglandin Thromboxane Res (1980) 0.78
Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev (2003) 5.77
beta-Actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mRNA levels. Thorax (2002) 4.11
Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2007) 3.74
Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax (2002) 3.58
Linkage of high-affinity IgE receptor gene with bronchial hyperreactivity, even in absence of atopy. Lancet (1995) 3.28
Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev (2000) 2.47
Anti-IgE for chronic asthma in adults and children. Cochrane Database Syst Rev (2006) 2.47
Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax (1999) 1.94
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2005) 1.91
Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis (1983) 1.85
Measurement of airway responsiveness to methacholine: relative importance of the precision of drug delivery and the method of assessing response. Thorax (1993) 1.76
Prevalence and residential determinants of fungi within homes in Melbourne, Australia. Clin Exp Allergy (1999) 1.69
Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation (1999) 1.69
Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med (2000) 1.67
Increased vascular permeability precedes cellular inflammation as asthma control deteriorates. Clin Exp Allergy (2009) 1.66
Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output. Thorax (1990) 1.61
IL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy. Eur Respir J (1997) 1.58
Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease. Intern Med J (2003) 1.55
A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax (2007) 1.54
Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness. Thorax (1988) 1.53
Adherence to asthma management guidelines by middle-aged adults with current asthma. Thorax (2009) 1.50
Oral corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2001) 1.50
Albumin is not suitable as a marker of bronchoalveolar lavage dilution in interstitial lung disease. Eur Respir J (1997) 1.48
Action plans for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2005) 1.47
Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels. Thorax (1981) 1.46
Residential characteristics influence Der p 1 levels in homes in Melbourne, Australia. Clin Exp Allergy (1999) 1.45
The rising prevalence of asthma in young Melbourne adults is associated with improvement in treatment. Ann Allergy Asthma Immunol (2001) 1.45
Reported food intolerance and respiratory symptoms in young adults. Eur Respir J (1998) 1.44
Intrasubject variability in airway inflammation sampled by bronchoalveolar lavage in stable asthmatics. Eur Respir J (1995) 1.43
What is evidence-based medicine and the role of the systematic review: the revolution coming your way. Monaldi Arch Chest Dis (2001) 1.40
Anti-IgE for chronic asthma. Cochrane Database Syst Rev (2003) 1.39
A cost-analysis of two approaches to infection control in a lung function laboratory. Aust N Z J Med (1999) 1.39
Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease. Thorax (2005) 1.37
Induction of bronchial hypersensitivity: evidence for a role for prostaglandins. Thorax (1981) 1.34
Reduced airway distensibility, fixed airflow limitation, and airway wall remodeling in asthma. Am J Respir Crit Care Med (2001) 1.33
Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev (2002) 1.33
The relationship between bronchial responsiveness to methacholine and bronchial responsiveness to histamine in asthmatic subjects. Pulm Pharmacol (1988) 1.33
Control of neurotransmission by prostaglandins in canine trachealis smooth muscle. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.27
Neutrophil depletion inhibits airway hyperresponsiveness induced by ozone exposure. Am Rev Respir Dis (1984) 1.23
Statistical approaches to the identification of late asthmatic reactions. Eur Respir J (1994) 1.22
An assessment of methacholine inhalation tests in elderly asthmatics. Age Ageing (1988) 1.19
Airway hyperresponsiveness and changes in cell counts in bronchoalveolar lavage after ozone exposure in dogs. Am Rev Respir Dis (1984) 1.18
Self-management education for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2003) 1.17
The relative contribution of bronchoalveolar macrophages and neutrophils to lucigenin- and luminol-amplified chemiluminescence. Eur Respir J (1990) 1.17
Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med (1995) 1.16
Comparison of patients with asthma managed in general practice and in a hospital clinic. Med J Aust (1999) 1.14
Reported adverse food reactions overestimate true food allergy in the community. Eur J Clin Nutr (2002) 1.13
Mouldy houses influence symptoms of asthma among atopic individuals. Clin Exp Allergy (2002) 1.12
Airway iron and iron-regulatory cytokines in cystic fibrosis. Eur Respir J (2004) 1.11
A critical evaluation of the Mefar dosimeter. Eur Respir J (1999) 1.11
Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev (2000) 1.09
Beta-agonists and asthma. Lancet (1993) 1.08
European Community Respiratory Health Survey calibration project of dosimeter driving pressures. Eur Respir J (2002) 1.08
Evaluation of a randomised controlled trial of adult asthma education in a hospital setting. Thorax (1999) 1.07
Anatomical distribution of bronchoalveolar lavage fluid as assessed by digital subtraction radiography. Thorax (1987) 1.07
Asthmatic airway biopsy specimens are more likely to express the IL-4 alternative splice variant IL-4delta2. J Allergy Clin Immunol (1999) 1.06
Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax (2000) 1.06
Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection. Am J Respir Crit Care Med (1998) 1.05
Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers. Thorax (1993) 1.05
Changes in bronchoalveolar lavage inflammatory cells in asthmatic patients treated with high dose inhaled beclomethasone dipropionate. Eur Respir J (1993) 1.05
Effect of a microaerosol barrier filter on the measurement of lung function. Chest (1995) 1.05
International prevalences of reported food allergies and intolerances. Comparisons arising from the European Community Respiratory Health Survey (ECRHS) 1991-1994. Eur J Clin Nutr (2001) 1.03
Fluid dynamics during bronchoalveolar lavage. Am Rev Respir Dis (1988) 1.03
Decreased lung capillary blood volume post-exercise is compensated by increased membrane diffusing capacity. Eur J Appl Physiol (2004) 1.01
Intrasubject variability in airway inflammation in biopsies in mild to moderate stable asthma. Am J Respir Crit Care Med (1996) 1.00
Indomethacin inhibits the airway hyperresponsiveness but not the neutrophil influx induced by ozone in dogs. Am Rev Respir Dis (1984) 1.00
Effects of inhaled fluticasone on angiogenesis and vascular endothelial growth factor in asthma. Thorax (2006) 1.00
Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med (2001) 1.00
Time-dependent effect of prostaglandin E2 inhalation on airway responses to bronchoconstrictor agents in normal subjects. Thorax (1982) 0.99
Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2005) 0.98
How have we been managing chronic obstructive pulmonary disease in Australia? Intern Med J (2006) 0.98
Changes in indoor allergen and fungal levels predict changes in asthma activity among young adults. Clin Exp Allergy (2005) 0.98
Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients. Thorax (1993) 0.97
Current indoor allergen levels of fungi and cats, but not house dust mites, influence allergy and asthma in adults with high dust mite exposure. Am J Respir Crit Care Med (2001) 0.96
Attendance at an asthma educational intervention: characteristics of participants and non-participants. Respir Med (1997) 0.96
A comparison of the speeds of action of salmeterol and salbutamol in reversing methacholine-induced bronchoconstriction. Pulm Pharmacol (1992) 0.96
Childhood adiposity predicts adult-onset current asthma in females: a 25-yr prospective study. Eur Respir J (2007) 0.96
The effects on asthmatics of exposure to a conventional water-based and a volatile organic compound-free paint. Eur Respir J (1997) 0.95
Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med (1994) 0.95
The usefulness of competitive PCR: airway gene expression of IL-5, IL-4, IL-4delta2, IL-2, and IFNgamma in asthma. Thorax (2001) 0.94
The prevalence of asthma and respiratory symptoms among young adults: is it increasing in Australia? J Asthma (1996) 0.94
Asthma management: how effective is it in the community? Intern Med J (2002) 0.94
Bronchoalveolar lavage cellular profiles in lung transplantation: the effect of inhaled corticosteroids. Ann Transplant (2000) 0.93
Immunomodulatory agents for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev (2003) 0.93
Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients. Eur Respir J (2002) 0.92
Fatty acid levels and risk of asthma in young adults. Thorax (2004) 0.92
Refractory period following bronchoconstriction provoked by histamine in asthmatic subjects. Thorax (1989) 0.92
Time to death, airway wall inflammation and remodelling in fatal asthma. Eur Respir J (2005) 0.91
Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis. Clin Exp Allergy (2005) 0.91
Prostacyclin for pulmonary hypertension in adults. Cochrane Database Syst Rev (2005) 0.91
Dual effect of prostaglandin E2 on normal airways smooth muscle in vivo. Thorax (1982) 0.90
Alveolar macrophages from atopic asthmatics, but not atopic nonasthmatics, enhance interleukin-5 production by CD4+ T cells. Am J Respir Crit Care Med (1998) 0.90
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. Cochrane Database Syst Rev (2006) 0.90
Bronchoalveolar lavage macrophage and lymphocyte phenotypes in lung transplant recipients. J Heart Lung Transplant (2001) 0.90
Quantitative detection of human cytomegalovirus DNA in lung transplant recipients. Am J Respir Crit Care Med (1997) 0.89
Salmeterol tachyphylaxis in steroid treated asthmatic subjects. Thorax (1996) 0.89
Airway versus transbronchial biopsy and BAL in lung transplant recipients: different but complementary. Eur Respir J (1997) 0.89
Effects of cardiac dysfunction on non-hypercapnic central sleep apnea. Chest (1998) 0.88
Airway distensibility in healthy and asthmatic subjects: effect of lung volume history. J Appl Physiol (1985) (2000) 0.88
Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo. Eur Respir J (2003) 0.88